Lazard Asset Management LLC Selecta Biosciences Inc Transaction History

Lazard Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.67 - $1.35 $406 - $819	-607 Reduced 5.17%	11,143 $7,000
Q3 2023 Nov 14, 2023	BUY	$1.02 - $1.23 $582 - $702	571 Added 5.11%	11,750 $12,000
Q2 2023 Aug 14, 2023	BUY	$1.04 - $1.4 $241 - $324	232 Added 2.12%	11,179 $12,000
Q1 2023 May 15, 2023	SELL	$1.15 - $1.89 $52,910 - $86,957	-46,009 Reduced 80.78%	10,947 $14,000
Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.6 $8,247 - $13,745	8,591 Added 17.76%	56,956 $64,000
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $64,325 - $125,749	48,365 New	48,365 $79,000
Q1 2022 May 13, 2022	SELL	$1.23 - $3.31 $22,838 - $61,460	-18,568 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$2.89 - $4.43 $17,105 - $26,221	5,919 Added 46.79%	18,568 $60,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $42,500 - $58,438	12,649 New	12,649 $52,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.